Pharmaceutical News and Articles

Chronic and New-Onset Anxiety Linked to All-Cause Dementia

Chronic and new-onset anxiety are associated with an increased risk for all-cause dementia, especially among those aged younger than 70 years, according to a st

Many U.S. Adults Lost Trust in Physicians, Hospitals During Pandemic

U.S. adults lost trust in physicians and hospitals during the COVID-19 pandemic, according to a study published online July 31 in JAMA Network Open.Roy H. Perli

Drug Approved to Fight Rare Cancer That Hits Young Adults

A new immunotherapy is now available to treat a rare soft tissue cancer that most frequently occurs in young men.The U.S. Food and Drug Administration has grant

Bystander CPR More Likely to Save Your Life If You're White and Male: Study

about 1 in 10.Around 40 of cardiac arrest victims received CPR from a bystander before paramedics could arrive, researchers found.On average, those who received

EPA Bans Vegetable Pesticide That Can Harm Fetuses

In an historic move, the Environmental Protection Agency on Tuesday banned the use of a pesticide that can harm fetuses.Known as dimethyl tetrachloroterephthala

Red Cross Issues Blood Shortage Alert as Summer Heat Cuts Donations

This summer s blistering temperatures have helped prompt an emergency blood shortage, the American Red Cross has warned.Heat waves affected almost 100 blood dri

More Than 1 in 4 Americans Over 50 Are Now Caregivers

More than 1 in 4 Americans 50 or older are now caregivers, looking after at least one family member or friend who has a health problem or disability, a new poll

FDA Approves Voranigo (vorasidenib) for the Treatment of Grade 2 IDH-Mutant Glioma

FDA Approves Tecelra as First Gene Therapy for Synovial Sarcoma

The U.S. Food and Drug Administration has approved Tecelra (afamitresgene autoleucel), a gene therapy for the treatment of adults with unresectable or metastati

Alopecia Tied to Higher Prevalence of Autoimmune, Psychiatric Comorbidities

Patients with alopecia areata (AA) have a higher prevalence of autoimmune and psychiatric comorbidities at time of diagnosis as well as a higher risk for new-on